A schistosome cAMP-dependent protein kinase catalytic subunit is essential for parasite viability.
Eukaryotes, protozoan, and helminth parasites make extensive use of protein kinases to control cellular functions, suggesting that protein kinases may represent novel targets for the development of anti-parasitic drugs. Because of their central role in intracellular signaling pathways, cyclic nucleotide-dependent kinases such as cAMP-dependent protein kinase (PKA) represent promising new targets for the treatment of parasitic infections and neoplastic disorders. However, the role of these kinases in schistosome biology has not been characterized and the genes encoding schistosome PKAs have not been identified. Here we provide biochemical evidence for the presence of a PKA signaling pathway in adult Schistosoma mansoni and show that PKA activity is required for parasite viability in vitro. We also provide the first full description of a gene that encodes a PKA catalytic subunit in S. mansoni, named SmPKA-C. Finally we demonstrate, through RNA interference, that SmPKA-C contributes to the PKA activity we detected biochemically and that inhibition of SmPKA-C expression in adult schistosomes results in parasite death. Together our data show that SmPKA-C is a critically important gene product and may represent an attractive therapeutic target for the treatment and control of schistosomiasis.
Swierczewski
Brett E
BE
Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America.
Davies
Stephen J
SJ
Biochim Biophys Acta. 2004 Mar 11;1697(1-2):155-68
15023358
Parasitol Res. 1989;75(5):368-74
2542928
Infect Immun. 1999 Aug;67(8):4183-90
10417190
Ann N Y Acad Sci. 2005 Nov;1058:76-86
16394127
Assay Drug Dev Technol. 2009 Feb;7(1):22-43
19382888
Trends Parasitol. 2008 Dec;24(12):570-7
18845480
Biochem J. 2000 Oct 1;351(Pt 1):95-105
10998351
Science. 2001 Nov 9;294(5545):1358-61
11701932
Parasitology. 2003 Mar;126(Pt 3):203-24
12666879
Am J Trop Med Hyg. 1999 Jun;60(6):932-5
10403323
J Biol Chem. 1989 May 25;264(15):8802-10
2722799
FASEB J. 1995 May;9(8):576-96
7768349
J Biol Chem. 1997 Nov 21;272(47):29560-5
9368018
Annu Rev Biochem. 1990;59:971-1005
2165385
Cell Signal. 2006 Dec;18(12):2230-7
16806821
Curr Opin Chem Biol. 1999 Aug;3(4):459-65
10419844
Acta Trop. 2002 May;82(2):139-46
12020886
Am J Trop Med Hyg. 1994 Jul;51(1):83-8
8059919
J Parasitol. 2004 Feb;90(1):8-14
15040661
Mol Biochem Parasitol. 2005 Oct;143(2):209-15
16076506
Genome Biol. 2003;4(5):111
12734000
PLoS Med. 2007 Jun;4(6):e206
17579510
Parasitol Res. 2003 Jun;90 Supp 1:S3-9
12811543
Mol Biochem Parasitol. 1982 Feb;5(2):107-16
7043262
Nature. 2001 May 17;411(6835):355-65
11357143
Cardiovasc Drug Rev. 2006 Fall-Winter;24(3-4):261-74
17214602
Adv Cyclic Nucleotide Protein Phosphorylation Res. 1986;20:1-150
3028083
Eukaryot Cell. 2002 Jun;1(3):317-28
12455981
Int J Parasitol. 2006 Oct;36(12):1261-72
16844129
Nature. 1992 Apr 16;356(6370):604-7
1560843
J Enzyme Inhib. 1991;5(2):87-98
1669444
Biochim Biophys Acta. 2008 Jan;1784(1):16-26
17996741
J Biol Chem. 1989 Aug 25;264(24):14579-84
2760075
Eur J Biochem. 1989 Apr 15;181(1):19-31
2540965
Cancer Res. 1992 May 1;52(9):2504-8
1314695
Methods. 2001 Dec;25(4):402-8
11846609
Bioessays. 2007 Dec;29(12):1281-8
18022808
Crit Rev Oncol Hematol. 1995 Nov;21(1-3):33-61
8822496
Curr Protoc Immunol. 2001 May;Chapter 19:Unit 19.1
18432750
J Biol Chem. 2002 May 3;277(18):15913-22
11834729
Eur J Biochem. 2001 Sep;268(18):4842-9
11559352
J Egypt Soc Parasitol. 1994 Dec;24(3):685-95
7844435
J Parasitol. 2002 Oct;88(5):849-55
12435119
Mol Biochem Parasitol. 2006 Mar;146(1):78-88
16325279
Trends Parasitol. 2006 Jul;22(7):322-6
16690357
Chem Biol. 2000 Jun;7(6):411-22
10873834